Northland Capital has recently reduced Cardlytics Inc (CDLX) stock to Market Perform rating, as announced on August 16, 2024, according to Finviz. Earlier, on August 15, 2024, BofA Securities had reduced the stock from a Neutral to Underperform, setting a price target of $3.50 for CDLX stock. Needham also reduced Hold rating. Additionally, Lake Street reduced Hold rating on August 8, 2024, with a target price of $5. Craig Hallum analysts, in their report published on August 8, 2024, also reduced Hold rating for Cardlytics Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
Cardlytics Inc (CDLX) Stock Trading Recap
On Tuesday, Cardlytics Inc (CDLX) stock saw a decline, ending the day at $3.11 which represents a decrease of $-0.09 or -2.81% from the prior close of $3.2. The stock opened at $3.23 and touched a low of $3.08 during the day, reaching a high of $3.25. The volume of shares traded was 1.25 million exceeding the average volume of 1.16 million.
CDLX Stock Performance and Moving Averages
In recent trading, Cardlytics Inc (CDLX) stock price has shown some volatility, fluctuating -7.16% over the last five trades and -20.46% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -77.22%, and it has plunged by -60.28% in the previous three months. Currently, CDLX is trading at -10.82%, -34.95%, and -62.50% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, CDLX, a Communication Services sector stock, is trading -84.84% below its 52-week high but remains 7.61% above its 52-week low. The Average True Range (ATR) (14 days) of 0.28 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Cardlytics Inc’s Profitability and Valuation Ratios
Cardlytics Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -19.15% and a profit margin of -50.21%, with a gross margin of -77.22%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Cardlytics Inc’s market capitalization stands at $155.00 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 0.51, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 0.73, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 4.90% of Cardlytics Inc (CDLX)’s shares, while financial institutions hold 68.56%.
Notable insider trades include DeSieno Alexis, Chief Financial Officer at Cardlytics Inc (CDLX), who sold 90912 shares on Aug 15 ’24, at $3.71 each, totaling $0.34 million. On Jul 24 ’24, Gupta Amit, Chief Operating Officer, sold 22699 shares for $8.66 each, amounting to $0.20 million. Additionally, on Jun 04 ’24, Temsamani Karim Saad sold 43129 shares at $8.65 each, generating $0.37 million.
